荣昌生物：第二届董事会第三十三次会议决议公告

Core Viewpoint - Rongchang Biotech announced the approval of multiple proposals at the 33rd meeting of its second board, including the conditions for the third vesting period of Class A restricted stock incentive plan and the first grant's second vesting period for Class B [1] Group 1 - The board meeting approved the proposal regarding the 2022 A-share restricted stock incentive plan [1] - The approval includes the conditions for the third vesting period of Class A rights [1] - The approval also covers the first grant's second vesting period for Class B rights [1]